Immunovant (IMVT) Shares Outstanding (Entity) (2018 - 2026)
Powered by 
Analysis
Immunovant (IMVT) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Immunovant | 8.13 Bn | 8.13 Bn | - | 206.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206.26 Mn |
| Mar 31, 2026 | 203.94 Mn |
| Dec 31, 2025 | 203.32 Mn |
| Sep 30, 2025 | 174.53 Mn |
| Jun 30, 2025 | 171.07 Mn |
| Mar 31, 2025 | 170.11 Mn |
| Dec 31, 2024 | 147.20 Mn |
| Sep 30, 2024 | 146.57 Mn |
| Jun 30, 2024 | 146.20 Mn |
| Mar 31, 2024 | 145.58 Mn |
| Dec 31, 2023 | 145.09 Mn |
| Sep 30, 2023 | 131.44 Mn |
| Jun 30, 2023 | 130.57 Mn |
| Mar 31, 2023 | 130.33 Mn |
| Dec 31, 2022 | 129.26 Mn |
| Sep 30, 2022 | 116.61 Mn |
| Jun 30, 2022 | 116.52 Mn |
| Mar 31, 2022 | 116.48 Mn |
| Dec 31, 2021 | 115.11 Mn |
| Sep 30, 2021 | 115.00 Mn |